$10,000 of HUMACYTE lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Trauma care"
You can find more data on corporate lobbying on Quiver Quantitative.
HUMA Insider Trading Activity
HUMA insiders have traded $HUMA stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HUMA stock by insiders over the last 6 months:
- KATHLEEN SEBELIUS purchased 50,000 shares for an estimated $66,000
- DALE A. SANDER (CFO and Chief Corp. Deve. Off.) purchased 20,000 shares for an estimated $30,600
- MICHAEL T. CONSTANTINO purchased 16,000 shares for an estimated $20,160
- SHAMIK J PARIKH (Chief Medical Officer) purchased 7,500 shares for an estimated $11,625
- WILLIAM JOHN SCHEESSELE (Chief Commercial Officer) purchased 6,493 shares for an estimated $9,999
- CHARLES BRUCE GREEN purchased 6,000 shares for an estimated $7,740
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HUMA Hedge Fund Activity
We have seen 95 institutional investors add shares of HUMA stock to their portfolio, and 68 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HEIGHTS CAPITAL MANAGEMENT, INC added 4,025,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $6,862,625
- RA CAPITAL MANAGEMENT, L.P. added 3,312,356 shares (+inf%) to their portfolio in Q1 2025, for an estimated $5,647,566
- CITADEL ADVISORS LLC added 2,740,439 shares (+1598.3%) to their portfolio in Q1 2025, for an estimated $4,672,448
- TORONTO DOMINION BANK added 2,131,390 shares (+inf%) to their portfolio in Q1 2025, for an estimated $3,634,019
- MONASHEE INVESTMENT MANAGEMENT LLC added 2,000,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $3,410,000
- WOODLINE PARTNERS LP added 1,101,198 shares (+38.7%) to their portfolio in Q1 2025, for an estimated $1,877,542
- MAVEN SECURITIES LTD added 1,049,828 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,789,956
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HUMA Analyst Ratings
Wall Street analysts have issued reports on $HUMA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- D. Boral Capital issued a "Buy" rating on 07/09/2025
- HC Wainwright & Co. issued a "Buy" rating on 05/14/2025
- Benchmark issued a "Buy" rating on 05/14/2025
To track analyst ratings and price targets for HUMA, check out Quiver Quantitative's $HUMA forecast page.
HUMA Price Targets
Multiple analysts have issued price targets for $HUMA recently. We have seen 4 analysts offer price targets for $HUMA in the last 6 months, with a median target of $14.5.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $25.0 on 07/09/2025
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $4.0 on 05/14/2025
- Bruce Jackson from Benchmark set a target price of $14.0 on 05/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
